This case details onset of systemic lupus erythematosus following olanzapine use, highlighting potential adverse effects.
Key Points
A 19-year-old female developed systemic lupus erythematosus after taking olanzapine for delusions, indicating potential links between the drug and serious side effects.
Laboratory results showed key indicators of lupus, including anemia with hemoglobin at 9 g/dL and severe leukopenia of 1000/mm³, strengthening the case for drug-induced SLE.
The report underscores the importance of monitoring for adverse effects in patients prescribed olanzapine, especially when presenting systemic symptoms.
This case informs clinicians about the necessity of considering olanzapine as a potential trigger for lupus in patients without typical SLE antibodies.